Clinical Trial Update: DiEtary Sodium Intake Effects on Ertugliflozin-induced Changes in GFR, reNal Oxygenation and Systemic Hemodynamics: the DESIGN Study, a Randomized, Placebo-controlled, Cross-over Study With Ertugliflozin in People With Type 2 Diabetes [Phase 4]

View source ↗

Summary

This is a Phase 4 randomized, crossover clinical trial evaluating how dietary sodium intake influences ertugliflozin-related changes in GFR, renal oxygenation, …

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Type 2 Diabetes Mellitus

Drugs mentioned

• STEGLATRO (ertugliflozin)

Snippet

Sponsor: Amsterdam UMC, location VUmc | Conditions: Type 2 Diabetes | Phase 4 | Status: RECRUITING